Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OMED

OncoMed Pharmaceuticals (OMED) Stock Price, News & Analysis

OncoMed Pharmaceuticals logo

About OncoMed Pharmaceuticals Stock (NASDAQ:OMED)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.89
$0.89
52-Week Range
N/A
Volume
1,201 shs
Average Volume
768,904 shs
Market Capitalization
$34.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OncoMed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

OMED Stock News Headlines

Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
Bispecific Antibody Market Size | Statistics By 2031
See More Headlines

OMED Stock Analysis - Frequently Asked Questions

OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) announced its quarterly earnings results on Thursday, November, 1st. The biopharmaceutical company reported $0.16 EPS for the quarter, beating analysts' consensus estimates of ($0.20) by $0.36. The biopharmaceutical company earned $19.52 million during the quarter, compared to analyst estimates of $7.97 million. OncoMed Pharmaceuticals had a negative net margin of 18.24% and a negative trailing twelve-month return on equity of 13.14%.

Based on aggregate information from My MarketBeat watchlists, some other companies that OncoMed Pharmaceuticals investors own include Esperion Therapeutics (ESPR), NXP Semiconductors (NXPI), Bristol Myers Squibb (BMY), Nightstar Therapeutics (NITE), GW Pharmaceuticals (GWPH), Celldex Therapeutics (CLDX) and Clovis Oncology (CLVS).

Company Calendar

Last Earnings
11/01/2018
Today
7/18/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:OMED
CIK
1302573
Fax
N/A
Employees
22
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.16)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.10 million
Net Margins
-18.24%
Pretax Margin
N/A
Return on Equity
-13.14%
Return on Assets
-7.73%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.04
Quick Ratio
5.04

Sales & Book Value

Annual Sales
$44.42 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.25 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
38,690,000
Free Float
N/A
Market Cap
$34.43 million
Optionable
Optionable
Beta
1.86
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:OMED) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners